Origin of the slow-binding inhibition of aldolase by D-glycero-tetrulose 1-phosphate (D-erythrulose 1-phosphate) from the comparison with the isosteric phosphonate analog

European Journal of Organic Chemistry

Volumn , Issue 11, 1999, Pages 2853-2857

  Page, Patrick ^a   Blonski, Casimir ^a   Périé, Jacques ^a  

^a CNRS   (France)

Author keywords

Aldolase; Bioorganic chemistry; Enzyme inhibitors; Enzyme mechanism; Structure activity relationship

Indexed keywords

ENZYME INHIBITOR; FRUCTOSE BISPHOSPHATE ALDOLASE; PHOSPHONIC ACID DERIVATIVE;

ARTICLE; COMPETITIVE INHIBITION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME MECHANISM; ORGANIC CHEMISTRY; REDUCTION; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

EID: 0032720421     PISSN: 1434193X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1099-0690(199911)1999:11<2853::aid-ejoc2853>3.0.co;2-0     Document Type: Article

References (44)

1. W. J. Rutter, Fed. Proc. Fed. Am. Soc. Exp. Biol. 1964, 23, 1248-1257.
2. [2a] E. Grazi, T. Cheng, B. L. Horecker, Biochem. Biophys. Res. Commun. 1962, 7, 250-253.
3. [2b] J. C. Speck, P. T. Rowly, B. L. Horecker, J. Am. Chem. Soc. 1963, 85, 1012-1013.
4. [2c] G. Avigad, S. Englard, Arch. Biochem. Biophys. 1972, 153, 337-346.
5. [2d] D. J. Kuo, I. A. Rose, Biochemistry 1985, 24, 3947-3952.
6. [2e] I. A. Rose. S. V. Rierder, J. Am. Chem. Soc. 1955, 77, 5764-5765.
7. [2f] B. Bloom, Y. J. Topper, Science 1956, 124, 982-983.
8. [2g] I. A. Rose, J. Am. Chem. Soc. 1958, 80, 5835-5836.
9. [2h] S. V. Rierder, I. A. Rose, J. Biol. Chem. 1959, 234, 1007-1010.
10. [2i] I. A. Rose, E. L. O'Connel, A. H. Mehler, J. Boil. Chem. 1965, 240, 1758-1765.
11. [2j] P. Christen, J. F. Riordan, Biochemistry 1968, 7, 1531.
12. [2k] M. J. Healy, P. Christen, Biochemistry 1973, 12, 35-41.
13. [2l] M. J. Healy, P. Christen, J. Am. Chem. Soc. 1972, 94, 7911-7916.
14. I. A. Rose, V. B. Warms, D. J. Kuo, J. Biol. Chem. 1987, 262, 692-701.
15. [4a] E. Grazi, G. Trombetta, Biochem. J. 1978, 175, 361-365.
16. [4b] E. Grazi, G. Trombetta, V. Lanzara, Biochemistry 1983, 22, 4434-4437.
17. [5a] T. C. Tung, K. H. Ling, W. L. Byrne, H. A. Lardy, Biochem. Biophys. Acta 1954, 14, 488-494.
18. [5b] A. H. Mehler, M. E. Cusic, Science 1967, 155, 1101-1103.
19. [5c] J. W. Gillett, C. E. Ballou, Biochemistry 1963, 2, 547-552.
20. [6a] J. F. Morrison, C. T. Walsh, Adv. Enzymol. Relat. Areas Mol. Biol. 1988, 61, 201-301.
21. [6b] J. V. Schloss, Acc. Chem. Res. 1988, 21, 348-353.
22. E. L. Ferroni, E. T. Harper, W. K. Fife, Biochem. Biophys. Res. Communs. 1991, 176, 511-516.
23. Aldolases are considered as targets for the development of new antiparasitic drugs since glycolysis is the only source of energy for parasites, such as trypanosome: [8a] F. R. Opperdoes, Ann. Rev. Microbiol. 1987, 41, 127-151.
24. [8b] T. Gefflaut, C. Blonski, J. Perie, M. Willson, Prog. Biophys. Molec. Biol. 1995, 63, 301-340.
25. [8c] J. Perie, I. Riviere-Alric, C. Blonski, T. Gefflaut, N. Lauth de Viguerie, M. Trinquier, M. Willson, F. R. Opperdoes, M. Callens, Pharmac. Ther. 1993, 60, 347-365.
26. [8d] C. Blonski, D. De Moissac, J. Perie, J. Sygusch, Biochem. J. 1997, 323, 71-77.
27. -1) and E the amount of enzyme subunit (μmol) used in the assay.
28. E. Abushanab, P. Vemishetti, R. W. Leiby, H. K.Singh, A. B. Mikkilienini, D. C. J. Wu, R. Saibaba, R. P. Panzica, J. Org. Chem. 1988, 53, 2598-2602.
29. Z. Li, S. Racha, L. Dan, H. El-Subbagh, E. Abushanab, J. Org. Chem. 1993, 58, 5779-5783.
30. K. E. Pfitzner, J. C. Moffat, J. Am. Chem. Soc. 1965, 87, 5670-5678
31. P. Page, C. Blonski, J. Perie, Biochem. Biophys. Acta 1998, 1386, 59-64.
32. Concentrations of 4 and aldolase were 1 mM and 5 μM repectively, the resulting loss of enzyme activity was 34%. In controls performed with DHAP (1 mM), or L-erythrulose 1-phosphate (1 mM) used instead of compound 4, the resulting losses of enzyme activity were 45% and 34%, respectively. In other controls where 4 or sodium tetrahydroborate were omitted, no significant loss of enzyme activity was detected (< 5%). For the assay performed with D-erythrulose 1-phosphate (1 mM), the sample was dialyzed for 18 h against an inhibitor-free solution prior to the measurement of the enzyme activity. The resulting irreversible loss of enzyme activity was 53%. In controls where D-erythrulose 1-phosphate or sodium tetrahydroborate were omitted, the loss of enzyme activity was 10%.
33. [15a] R. F. Pratt, Biochemistry 1977, 16, 3988-3994.
34. [15b] G. Lowe, R. F. Pratt, Eur. J. Biochem. 1976, 66, 95-104.
35. 1H-NMR spectroscopy, or by oxidation by hexacyanoferrate(III), failed due possibly to the enzyme inhibition.
36. [17a] R. Iyengar, I. A. Rose, J. Am. Chem. Soc. 1983, 105, 330.
37. [17b] J. P. Richard, J. Am. Chem. Soc. 1984, 106, 4926-4936.
38. [17c] J. P. Richard, Biochem. Soc. Trans. 1993, 21, 549-553.
39. I. A. Rose, E. L. O'Connel, J. Biol. Chem. 1969, 244, 6548-6550.
40. A. Ginsburg, A. H. Mehler, Biochemistry 1966, 5, 2623-2634.
41. M. D. Bednarski, E. S. Simon, N. Bischofberger, W.-D. Fessner, M.-J. Kim, W. Lees, T. Saito, H. Waldmann, G. M. Whitesides, J. Am. Chem. Soc. 1989, 111, 627-635.
42. E. Racker, J. Biol. Chem. 1947, 167, 843-854.
43. T. Baranowski, T. R. Niederland, J. Biol. Chem. 1949, 180, 543-551.
44. E. Grazi, C. Sivieri-Pecorari, R. Gagliano, G. Trombetta, Biochemistry 1973, 12, 2583-2590.